Candel Therapeutics (CADL) Insider Trading & Ownership $8.75 -1.21 (-12.15%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Candel Therapeutics (NASDAQ:CADL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage41.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$7.50 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$909,547.13 Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CADL Insider Buying and Selling by Quarter Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Candel Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/16/2024Paul B ManningDirectorBuy1,250,000$6.00$7,500,000.00 11/29/2024Seshu TyagarajanCTOSell20,392$4.56$92,987.52 11/29/2024William Garrett NicholsInsiderSell13,935$4.56$63,543.60 10/14/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.02$90,300.00 10/11/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.05$90,750.00 10/3/2024Estuardo Aguilar-CordovaMajor ShareholderSell1,800$6.85$12,330.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/17/2024Charles SchochInsiderSell9,884$6.47$63,949.48 7/17/2024Paul Peter TakCEOSell22,528$6.47$145,756.16 7/17/2024Seshu TyagarajanCTOSell14,851$6.47$96,085.97 7/11/2024Charles SchochInsiderSell8,897$5.97$53,115.09 7/11/2024Paul Peter TakCEOSell20,293$5.97$121,149.21 7/11/2024Seshu TyagarajanCTOSell13,330$5.97$79,580.10 (Data available from 1/1/2013 forward) CADL Insider Trading Activity - Frequently Asked Questions Who is on Candel Therapeutics's Insider Roster? The list of insiders at Candel Therapeutics includes Charles Schoch, Estuardo Aguilar-Cordova, Francesca Barone, Jason Amello, Joseph C Papa, Paul B Manning, Paul Peter Tak, Seshu Tyagarajan, and William Garrett Nichols. Learn more on insiders at CADL. What percentage of Candel Therapeutics stock is owned by insiders? 41.60% of Candel Therapeutics stock is owned by insiders. Learn more on CADL's insider holdings. Which Candel Therapeutics insiders have been buying company stock? The following insider purchased CADL shares in the last 24 months: Paul B Manning ($7,500,000.00). How much insider buying is happening at Candel Therapeutics? Insiders have purchased a total of 1,250,000 CADL shares in the last 24 months for a total of $7,500,000.00 bought. Which Candel Therapeutics insiders have been selling company stock? The following insiders have sold CADL shares in the last 24 months: Charles Schoch ($117,064.57), Estuardo Aguilar-Cordova ($193,380.00), Paul Peter Tak ($266,905.37), Seshu Tyagarajan ($268,653.59), and William Garrett Nichols ($63,543.60). How much insider selling is happening at Candel Therapeutics? Insiders have sold a total of 155,910 Candel Therapeutics shares in the last 24 months for a total of $909,547.13 sold. Candel Therapeutics Key ExecutivesDr. Paul-Peter Tak FMEDSCI (Age 63)M.D., Ph.D., President, CEO & Director Compensation: $1.12MDr. Estuardo Aguilar-Cordova Inf. (Age 65)M.D., Ph.D., Founder & Director Compensation: $35k3 recent tradesDr. Francesca Barone M.D. (Age 46)Ph.D., Chief Scientific Officer Compensation: $506.76kMr. Charles Schoch (Age 39)Interim CFO, VP of Finance & Corporate Controller 2 recent tradesDr. Seshu Tyagarajan Ph.D. (Age 56)Chief Technical & Development Officer Compensation: $335.27kMs. Ileen B. WinickChief People OfficerMs. Susan Stewart J.D. (Age 63)L.L.M., Chief Regulatory Officer Dr. William Garrett Nichols M.D. (Age 55)M.S., Chief Medical Officer 1 recent trades More Insider Trading Tools from MarketBeat Related Companies IMNM Insider Buying KURA Insider Buying KROS Insider Buying TYRA Insider Buying CRON Insider Buying ERAS Insider Buying EOLS Insider Buying DNTH Insider Buying RAPP Insider Buying CGEM Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:CADL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CADL Stock Alerts